Top 10 at 11: Drug trial progress and coal success are today’s news

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms that have made announcements.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading. Here’s what’s happened so far.

Pre-market, the ASX was expected to open lower this morning, after Wall Street took a kicking overnight.

The big news there is that fast food giant McDonald’s fell heavily on reports that one person has died and 49 more hospitalised after an E. coli outbreak in the US linked to the chain’s famous Quarter Pounder burgers.

Locally, there’s still a lot of chatter about the place surrounding Wisetech Global and whether Richard White should stand aside in the wake of his infidelity scandals, with shareholders unhappy at the shockingly large fall in share price it’s caused.

When the market opened, MAterials and InfoTech led the sell-off, sending the ASX 200 benchmark down 0.35% in the opening minutes of the session.

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code	Company	Price	%	Volume	Market Cap
CRB	Carbine Resources	0.004	33.3	252,857	$1,655,213
AAU	Antilles Gold	0.005	25.0	544,488	$7,422,971
ASQ	Australian Silica	0.041	24.2	998	$9,301,392
AVE	Avecho Biotech	0.003	20.0	200,000	$7,923,243
PRX	Prodigy Gold	0.003	20.0	393,209	$5,831,140
BTE	Botala Energy	0.07	16.7	7,428	$11,962,176
CHM	Chimeric Therapeutic	0.0105	16.7	6,162,416	$8,146,349
BCB	Bowen Coal	0.008	14.3	5,606,367	$20,513,428
IPB	IPB Petroleum	0.008	14.3	62,500	$4,944,821
SHE	Stonehorse Energy	0.008	14.3	622,000	$4,791,046

Chimeric Therapeutics (ASX:CHM) was up on news that the company’s Phase 1B ADVENT-AML clinical trial has completed enrolment of relapsed or refractory Acute Myeloid Leukaemia subjects in the dose-finding portion of the clinical trial. The trial is an investigator-initiated study currently open to enrolment at The University of Texas MD Anderson Cancer Center under Principal Investigator Abhishek Maiti MD, Assistant Professor in the Department of Leukaemia.

Bowen Coking Coal (ASX:BCB) released its quarterly this morning, announcing that “robust mining performance” has delivered 769Kt ROM for the quarter, while the company has managed a mining cost reduction of 7% to $53/ROMt including boxcut costs and 52% lower than this time last year. That has led to 444Kt of saleable coal produced with sales of 415Kt recorded in the quarter, at an average coal price of A$216/t, down slightly on pcp.

LAGGARDS

Stocks highlighted in red have made market-moving announcements (click headings to sort).

Code	Company	Price	%	Volume	Market Cap
RLC	Reedy Lagoon	0.002	-33.3	136,500	$1,858,622
MTL	Mantle Minerals	0.0015	-25.0	310,000	$12,394,892
ALY	Alchemy Resource	0.007	-22.2	600,000	$10,602,686
G88	Golden Mile Resources	0.012	-20.0	131,007	$6,168,343
GTR	Gti Energy	0.004	-20.0	92,660	$14,802,248
ICU	Investor Centre	0.004	-20.0	582,126	$1,522,557
GTI	Gratifii	0.005	-16.7	156,000	$12,895,177
LOT	Lotus Resources	0.27	-14.3	7,244,878	$577,573,751
JAL	Jameson Resources	0.055	-14.1	138,174	$39,086,933
HMD	HeraMED	0.02	-13.0	762,594	$14,564,746

At Stockhead we tell it like it is. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.